Your browser doesn't support javascript.
loading
Repurposing of FDA-approved antivirals, antibiotics, anthelmintics, antioxidants, and cell protectives against SARS-CoV-2 papain-like protease.
Kandeel, Mahmoud; Abdelrahman, Alaa H M; Oh-Hashi, Kentaro; Ibrahim, Abdelazim; Venugopala, Katharigatta N; Morsy, Mohamed A; Ibrahim, Mahmoud A A.
Affiliation
  • Kandeel M; Department of Biomedical Sciences, College of Veterinary Medicine, King Faisal University, Al-ahsa, Saudi Arabia.
  • Abdelrahman AHM; Department of Pharmacology, Faculty of Veterinary Medicine, Kafrelshikh University, Kafrelshikh, Egypt.
  • Oh-Hashi K; Computational Chemistry Laboratory, Chemistry Department, Faculty of Science, Minia University, Minia, Egypt.
  • Ibrahim A; Department of Chemistry and Biomolecular Science, Faculty of Engineering, Gifu University, Gifu, Japan.
  • Venugopala KN; Department of Pathology, College of Veterinary Medicine, King Faisal University, Al-ahsa, Saudi Arabia.
  • Morsy MA; Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa, Saudi Arabia.
  • Ibrahim MAA; Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa, Saudi Arabia.
J Biomol Struct Dyn ; 39(14): 5129-5136, 2021 09.
Article in En | MEDLINE | ID: mdl-32597315
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 / Anthelmintics Type of study: Guideline / Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: J Biomol Struct Dyn Year: 2021 Type: Article Affiliation country: Saudi Arabia
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 / Anthelmintics Type of study: Guideline / Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: J Biomol Struct Dyn Year: 2021 Type: Article Affiliation country: Saudi Arabia